Meeting of the Uniform Formulary Beneficiary Advisory Panel, 47491 [06-6981]

Download as PDF Federal Register / Vol. 71, No. 159 / Thursday, August 17, 2006 / Notices Defense and the Under Secretary of Defense for Acquisition, Technology & Logistics on scientific and technical matters as they affect the perceived needs of the Department of Defense. At these meetings, the Defense Science Board Task Force will: Describe the defense industry required to cope with the international security environment in the 21st century. Additionally the task force will address the implications for the industrial base of increased DoD acquisition of services, as well as the implications for the financial viability of the defense industrial base as the sector adapts to changing DoD needs for defense-related products and services. In accordance with Section 10(d) of the Federal Advisory Committee Act, Pub. L. 92–463, as amended (5 U.S.C. App. II), it has been determined that these Defense Science Board Task Force meetings concern matters listed in 5 U.S.C. 552b(c)(1) and that, accordingly, the meetings will be closed to the public. MAJ Chad Lominac, USAF, Defense Science Board, 3140 Defense Pentagon, Room 3C553, Washington, DC 20301–3140, via E-mail at charles.lominac@osd.mil, or via phone at (703) 571–0081. FOR FURTHER INFORMATION CONTACT: Dated: August 10, 2006. L.M. Bynum, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 06–6982 Filed 8–16–06; 8:45 am] The mission of the Defense Science Board is to advise the Secretary of Defense and the Under Secretary of Defense for Acquisition, Technology & Logistics on scientific and technical matters as they affect the perceived needs of the Department of Defense. At these meetings, the Defense Science Board Task Force will: Describe the defense industry required to cope with the international security environment in the 21st century. Additionally the task force will address the implications for the industrial base of increased DoD acquisition of services, as well as the implications for the financial viability of the defense industrial base as the sector adapts to changing DoD needs for defense-related products and services. In accordance with Section 10(d) of the Federal Advisory Committee Act, Public Law 92–463, as amended (5 U.S.C. App. II), it has been determined that these Defense Science Board Task Force meetings concern matters listed in 5 U.S.C. 552b(c)(1) and that, accordingly, the meetings will be closed to the public. FOR FURTHER INFORMATION CONTACT: MAJ Chad Lominac, USAF, Defense Science Board, 3140 Defense Pentagon, Room 3C553, Washington, DC 20301–3140, via Email at charles.lominac@osd.mil, or via phone at (703) 571–0081. Dated: August 10, 2006. L.M. Bynum, OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 06–6983 Filed 8–16–06; 8:45 am] BILLING CODE 5001–06–M BILLING CODE 5001–06–M DEPARTMENT OF DEFENSE 47491 Thursday, September 21, 2006, from 8 a.m. to 4 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 703–681– 2890, ext. 6718, fax 703–681–1940, or Email at baprequests@tma.osd.mil. SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory Panel will only review and comment on the development of the Uniform Formulary as reflected in the recommendations of the DOD Pharmacy and Therapeutics (P&T) Committee coming out of that body’s meeting in August 2006. The P&T Committee information and subject matter concerning drug classes reviewed for that meeting are available at https:// pec.ha.osd.mil. Any private citizen is permitted to file a written statement with the advisory panel. Statements must be submitted electronically to baprequests@tma.osd.mil no later than September 14, 2006. Any private citizen is permitted to speak at the Beneficiary Advisory Panel meeting, time permitting. One hour will be reserved for public comments, and speaking times will be assigned only to the first twelve citizens to sign up at the meeting, on a first-come, first-served basis. The amount of time allocated to a speaker will not exceed five minutes. DATES: Dated: August 10, 2006. L.M. Bynum, OSD Federal Register Liaison Officer, DoD. [FR Doc. 06–6981 Filed 8–16–06; 8:45 am] Office of the Secretary DEPARTMENT OF DEFENSE Defense Science Board Office of the Secretary Department of Defense. ACTION: Notice of Advisory Committee Meetings. Meeting of the Uniform Formulary Beneficiary Advisory Panel BILLING CODE 5001–06–M rwilkins on PROD1PC63 with NOTICES AGENCY: SUMMARY: The Defense Science Board Task Force on Defense Industrial Structure for Transformation will meet in closed session on October 10, 2006, at Science Applications International Corporation (SAIC), 4001 N. Fairfax Drive, Arlington, VA. This meeting will characterize the degree of change needed in industry due to the changing nature of DoD and the industrial Base. It will also examine the effectiveness of existing mitigation measures and make recommendations to ensure future competition and innovation throughout all tiers of the defense industrial base. The briefings will contain proprietary material and ensuing discussions will be at the collateral secret level. VerDate Aug<31>2005 16:36 Aug 16, 2006 Jkt 208001 Department of Defense, Assistant Secretary of Defense (Health Affairs). ACTION: Notice of Meeting. AGENCY: SUMMARY: This notice announces a meeting of the Uniform Formulary Beneficiary Advisory Panel. The panel will review and comment on recommendations made to the Director, TRICARE Management Activity, by the Pharmacy and Therapeutics Committee regarding the Uniform Formulary. The meeting will be open to the public. Seating is limited and will be provided only to the first 220 people signing in. All persons must sign in legibly. Notice of this meeting is required under the Federal Advisory Committee Act. PO 00000 Frm 00013 Fmt 4703 Sfmt 4703 DEPARTMENT OF ENERGY Environmental Management SiteSpecific Advisory Board, Northern New Mexico Department of Energy. Notice of open meeting. AGENCY: ACTION: SUMMARY: This notice announces a meeting of the Environmental Management Site-Specific Advisory Board (EM SSAB), Northern New Mexico. The Federal Advisory Committee Act (Pub. L. 92–463, 86 Stat. 770) requires that public notice of this meeting be announced in the Federal Register. Wednesday, September 27, 2006, 2 p.m.–8:30 p.m. DATES: E:\FR\FM\17AUN1.SGM 17AUN1

Agencies

[Federal Register Volume 71, Number 159 (Thursday, August 17, 2006)]
[Notices]
[Page 47491]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 06-6981]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Meeting of the Uniform Formulary Beneficiary Advisory Panel

AGENCY: Department of Defense, Assistant Secretary of Defense (Health 
Affairs).

ACTION: Notice of Meeting.

-----------------------------------------------------------------------

SUMMARY: This notice announces a meeting of the Uniform Formulary 
Beneficiary Advisory Panel. The panel will review and comment on 
recommendations made to the Director, TRICARE Management Activity, by 
the Pharmacy and Therapeutics Committee regarding the Uniform 
Formulary. The meeting will be open to the public. Seating is limited 
and will be provided only to the first 220 people signing in. All 
persons must sign in legibly. Notice of this meeting is required under 
the Federal Advisory Committee Act.

DATES: Thursday, September 21, 2006, from 8 a.m. to 4 p.m.

ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., 
Washington, DC 20004.

FOR FURTHER INFORMATION CONTACT: Mr. Rich Martel, TRICARE Management 
Activity, Pharmaceutical Operations Directorate, Beneficiary Advisory 
Panel, Suite 810, 5111 Leesburg Pike, Falls Church, VA 22041, telephone 
703-681-2890, ext. 6718, fax 703-681-1940, or Email at 
baprequests@tma.osd.mil.

SUPPLEMENTARY INFORMATION: The Uniform Formulary Beneficiary Advisory 
Panel will only review and comment on the development of the Uniform 
Formulary as reflected in the recommendations of the DOD Pharmacy and 
Therapeutics (P&T) Committee coming out of that body's meeting in 
August 2006. The P&T Committee information and subject matter 
concerning drug classes reviewed for that meeting are available at 
https://pec.ha.osd.mil. Any private citizen is permitted to file a 
written statement with the advisory panel. Statements must be submitted 
electronically to baprequests@tma.osd.mil no later than September 14, 
2006. Any private citizen is permitted to speak at the Beneficiary 
Advisory Panel meeting, time permitting. One hour will be reserved for 
public comments, and speaking times will be assigned only to the first 
twelve citizens to sign up at the meeting, on a first-come, first-
served basis. The amount of time allocated to a speaker will not exceed 
five minutes.

    Dated: August 10, 2006.
L.M. Bynum,
OSD Federal Register Liaison Officer, DoD.
[FR Doc. 06-6981 Filed 8-16-06; 8:45 am]
BILLING CODE 5001-06-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.